Synthetic Multivalent Glycopeptide-Lipopeptide Antitumor Vaccines: Impact of the Cluster Effect on the Killing of Tumor Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic Multivalent Glycopeptide-Lipopeptide Antitumor Vaccines: Impact of the Cluster Effect on the Killing of Tumor Cells
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 53, Issue 6, Pages 1699-1703
Publisher
Wiley
Online
2014-01-22
DOI
10.1002/anie.201308875
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Water-Soluble Polymers Coupled with Glycopeptide Antigens and T-Cell Epitopes as Potential Antitumor Vaccines
- (2013) Lutz Nuhn et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Self-Adjuvanting Synthetic Antitumor Vaccines from MUC1 Glycopeptides Conjugated to T-Cell Epitopes from Tetanus Toxoid
- (2013) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The development of synthetic antitumour vaccines from mucin glycopeptide antigens
- (2013) Nikola Gaidzik et al. CHEMICAL SOCIETY REVIEWS
- Chemical assembly of N-glycoproteins: a refined toolbox to address a ubiquitous posttranslational modification
- (2013) Carlo Unverzagt et al. CHEMICAL SOCIETY REVIEWS
- Variation of the Glycosylation Pattern in MUC1 Glycopeptide BSA Vaccines and Its Influence on the Immune Response
- (2012) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Fully Synthetic Self-Adjuvanting Thioether-Conjugated GlycopeptideLipopeptide Antitumor Vaccines for the Induction of Complement-Dependent Cytotoxicity against Tumor Cells
- (2012) Hui Cai et al. CHEMISTRY-A EUROPEAN JOURNAL
- a Totally Synthetic, Self-Assembling, Adjuvant-Free MUC1 Glycopeptide Vaccine for Cancer Therapy
- (2012) Zhi-Hua Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer
- (2011) Brendan L. Wilkinson et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthetic Antitumor Vaccines Containing MUC1 Glycopeptides with Two Immunodominant Domains-Induction of a Strong Immune Response against Breast Tumor Tissues
- (2011) Nikola Gaidzik et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Towards a Fully Synthetic MUC1-Based Anticancer Vaccine: Efficient Conjugation of Glycopeptides with Mono-, Di-, and Tetravalent Lipopeptides Using Click Chemistry
- (2011) Hui Cai et al. CHEMISTRY-A EUROPEAN JOURNAL
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- Glycodendrimers as functional antigens and antitumor vaccines
- (2011) Tze Chieh Shiao et al. NEW JOURNAL OF CHEMISTRY
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
- (2011) V. Lakshminarayanan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fully Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopeptides and a Lipopeptide Ligand of the Toll-like Receptor 2
- (2010) Anton Kaiser et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Polyacrylate Dendrimer Nanoparticles: A Self-Adjuvanting Vaccine Delivery System
- (2010) Mariusz Skwarczynski et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthesis of MUC1–lipopeptide chimeras
- (2010) Brendan L. Wilkinson et al. CHEMICAL COMMUNICATIONS
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- A Synthetic Vaccine Consisting of a Tumor-Associated Sialyl-TN-MUC1 Tandem-Repeat Glycopeptide and Tetanus Toxoid: Induction of a Strong and Highly Selective Immune Response
- (2009) Anton Kaiser et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy
- (2009) Sergey S Seregin et al. MOLECULAR THERAPY
- Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopeptide Antigens and a T-Cell Epitope for the Induction of a Highly Specific Humoral Immune Response
- (2008) Ulrika Westerlind et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
- (2008) M. Dechant et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now